Arun Mathur, MD
Otolaryngology/Facial Plastic Surgery · Wooster, OHNPI 1396805362
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Acclarent, Inc accounts for 63.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $146 and has fallen 66.3% since, to $49 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in OH, where the typical reported total is $1,402.
Across 19 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$296
- Integra Lifesciences Corporation$49
- Regeneron Healthcare Solutions, Inc.$33
- Sanofi-aventis U.S. LLC$29
- Stryker$19
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$18
- plus $24 from 2 others
What the payments were for
- Food & beverage$43894%
- Education$296%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 11 | $296 |
| Integra Lifesciences Corporation | 1 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Stryker | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Medline Industries LP | 1 | $13 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$467 in reported general payments places this provider in the 30th percentile of 29 otolaryngology/facial plastic surgery providers in Ohio.
See all otolaryngology/facial plastic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 62 | $3,272 |
| Ipratropium Bromide | 69 | $1,553 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 25 | $1,289 |
| Cefdinir | 75 | $1,239 |
| Pantoprazole Sodium | 32 | $186 |
| Methylprednisolone | 28 | $146 |
| Fluticasone Propionate | 12 | $103 |
| Triamcinolone Acetonide | 32 | $86 |
| Omeprazole | 13 | $84 |
| Levofloxacin | 15 | $43 |
| Azithromycin | 12 | $28 |
| Hydrochlorothiazide | 19 | $21 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Wooster
- James HesslerWooster$121
- Howard LevineCleveland$65K
- Joseph ScharpfCleveland$12K
- Tsung-Yen HsiehCincinnati$9K
- Kevin ShumrickCincinnati$6K
- Matthew LutzStow$6K
- Avi ShawBoardman$6K
- Ryan GerritsenAkron$5K
- Eric LamarreCleveland$4K
- Phillip KhalilStow$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.